Trial intelligence / Profile preview

Sitagliptin phosphate plus metformin vs placebo plus metformin in Chinese adults with type 2 diabetes mellitus

CTR20200157Phase 3Completed

Sponsor
Centaurus Biopharma
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Centaurus Biopharma. Started Feb 2020; status: completed.

02

Drugs

sitagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on CTR20200157.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20200157.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call